Cree Receives Consensus Recommendation of “Hold” from Brokerages (NASDAQ:CREE)
Shares of Cree (NASDAQ:CREE) have earned an average recommendation of “Hold” from the twenty-four brokerages that are presently covering the company, ARN reports. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $58.38.
Several analysts have recently commented on the stock. Analysts at Zacks downgraded shares of Cree from a “neutral” rating to an “underperform” rating in a research note on Tuesday, August 19th. They now have a $42.90 price target on the stock. Separately, analysts at TheStreet upgraded shares of Cree to a “buy” rating in a research note on Thursday, August 14th. Finally, analysts at Susquehanna reiterated a “neutral” rating on shares of Cree in a research note on Wednesday, August 13th. They now have a $42.00 price target on the stock, down previously from $50.00.
Cree (NASDAQ:CREE) opened at 45.15 on Wednesday. Cree has a 1-year low of $43.66 and a 1-year high of $75.98. The stock has a 50-day moving average of $47.9 and a 200-day moving average of $52.12. The company has a market cap of $5.510 billion and a P/E ratio of 44.62.
Cree (NASDAQ:CREE) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.01. The company had revenue of $436.30 million for the quarter, compared to the consensus estimate of $444.11 million. During the same quarter in the previous year, the company posted $0.38 earnings per share. On average, analysts predict that Cree will post $1.85 earnings per share for the current fiscal year.
Cree, Inc (NASDAQ:CREE) develops and manufactures semiconductor materials and devices primarily based on silicon carbide (SiC), gallium nitride (GaN) and related compounds.
Receive News & Ratings for Cree Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cree Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.